What’s Next For Castle Biosciences Stock?
- Thursday, November 11, 2021, 7:30
- Market
- Add a comment
The stock price of Castle Biosciences (NASDAQ: CSTL), a skin cancer diagnostic company, has seen a fall of over 9% last month, while it is down 12% in a week. The recent fall can be attributed to its downbeat Q3 results. Castle Biosciences reported revenue of $23.5 million, slightly above the…
About the Author
admin123 has written 23519 stories on this site.
